全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Mikkel B. Christensen , Helena Domínguez ...
来源:[J].BMC Health Services Research(IF 1.773), 2017, Vol.17 (1)Springer
摘要:Multimorbidity is becoming increasingly prevalent and presents challenges for healthcare providers and systems. Studies examining the relationship between multimorbidity and quality of care report mixed findings. The purpose of this study was to investigate quality of care for pe...
作者:Andreas Brønden , Filip K. Knop , Mikkel B. Christensen
来源:[J].Clinical Pharmacokinetics(IF 6.109), 2017, Vol.56 (7), pp.719-731Springer
摘要:Albiglutide is a long-acting, glucagon-like peptide-1 receptor agonist for subcutaneous administration with a recommended dose of 30–50 mg once weekly. The aim of this article is to outline the pharmacokinetic and pharmacodynamic properties of albiglutide including the clini...
作者:Mikkel B. Christensen , Salvatore Calanna ...
来源:[J].The Journal of Clinical Endocrinology & Metabolism(IF 6.43), 2014, Vol.99 (3), pp.E418-E426Wolters Kluwer
摘要:CONTEXT:: Patients with type 2 diabetes mellitus (T2DM) have clinically relevant disturbances in the effects of the hormone glucose-dependent insulinotropic polypeptide (GIP). OBJECTIVE:: We aimed to evaluate the importance of the prevailing plasma glucose levels for the eff...
作者:Mikkel B. Christensen , Tina Vilsbøll
来源:[J].International Journal of Molecular Sciences(IF 2.464), 2019, Vol.20 (17)MDPI
摘要:The gut-derived incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are secreted after meal ingestion and work in concert to promote postprandial insulin secretion. Furthermore, GLP-1 inhibits glucagon secretion when plasma glu...
作者:... Thomas B. Jensen , Kim P. Dalhoff , Mikkel B. Christensen
来源:[J].Clinical Chemistry and Laboratory Medicine (CCLM)(IF 3.009), 2018, Vol.56 (12), pp.2047-2057De Gruyter
摘要:Abstract Background Intravenous lipid emulsion (ILE) is used to treat drug poisonings. The resultant hyperlipemia may affect laboratory tests but the consequences are poorly characterized. In a clinical trial we therefore investigated the effects of ILE on laboratory tests a...
作者:Mikkel B. Christensen , Filip K. Knop
来源:[J].PLOS ONE(IF 3.73), 2016, Vol.11 (11)PLOS
摘要:Sodium-glucose co-transporter 2 inhibitors (SGLT2-i) are a novel drug class for the treatment of diabetes. We aimed at describing the maximal benefits and risks associated with SGLT2-i for patients with type 2 diabetes.;;Systematic review and meta-analysis.;;We included doub...
作者:... Tonny S. Petersen , Jonatan Kornholt , Mikkel B. Christensen
来源:[J].Pharmacology Research & Perspectives, 2018, Vol.6 (6), pp.n/a-n/aWiley
摘要:Abstract(#br)Polypharmacy is common among multimorbid adults and associated with increased morbidity and mortality. Excessive polypharmacy (ie, ≥10 medicine) is strongly associated with inappropriate medication use, but little is known about attitudes toward deprescribing in...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×